Published 6 March 2015 New research shows that it is possible to predict the development of type 1 diabetes. By measuring the presence of autoantibodies in the blood, it is possible to detect whether the immune system has begun to break down the bodys own insulin cells. "In the TEDDY study we have found that autoantibodies often appear during the first few years of life", said professor Åke Lernma

https://www.ludc.lu.se/article/early-signs-young-children-predict-type-1-diabetes - 2025-04-29

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 3 December 2019 New results from the Environmental Determinants of Diabetes in the Young (TEDDY) study showed an association between prolonged enterovirus infection and the development of autoimmunity to the insulin-producing pancreatic beta-cells that precedes type 1 diabetes (T1D). Notably, researchers also found that

https://www.ludc.lu.se/article/unexpected-viral-behavior-linked-type-1-diabetes-high-risk-children - 2025-04-29

Published 17 December 2019 Sweden and Denmark are among the countries in the world with the highest type-1 diabetes prevalence. Both countries have a long tradition of excellent research and treatment, and with the new joint diabetes project DiaUnion, supported by the EU's Interreg program, we are bridging research among the two countries to jointly put in an extra effort to fight the deadly disea

https://www.ludc.lu.se/article/denmark-and-sweden-join-forces-against-diabetes - 2025-04-29

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 17 December 2019 Using lipidomics, a technique that measures the composition of blood lipids at a molecular level, and machine learning, researchers at Lund University in Sweden have identified a blood lipid profile that improves the possibility to assess, several years in advance, the risk of developing type 2 diabetes.

https://www.ludc.lu.se/article/blood-lipid-profile-predicts-risk-type-2-diabetes-better-obesity - 2025-04-29

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 3 February 2020 Niels Grarup, Novo Nordisk Foundation Centre for Basic Metabolic Research at the University of Copenhagen, will recieve the Leif C. Groop Award for Outstanding Diabetes Research. In his research, he has shown, among other things, that there is a genetic explanation for the increase in type 2 diabetes in G

https://www.ludc.lu.se/article/award-research-gene-increases-risk-type-2-diabetes-greenland - 2025-04-29

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 31 January 2020 One of Europe’s largest type 1 diabetes research cooperations has passed a significant milestone: The international platform GPPAD (“The Global Platform for the Prevention of Autoimmune Diabetes”) has successfully included 520 babies across Europe in the type 1 diabetes prevention trial POInT (Primary Ora

https://www.ludc.lu.se/article/halfway-there-biggest-type-1-diabetes-prevention-trial-babies-reaches-important-milestone - 2025-04-29

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 12 February 2020 Stina Ramne is the recipient of the DPLU PhD Student Prize 2019. In her research in nutritional epidemiology she focuses on intake of added sugar and risk of diabetes and cardiometabolic disease. In the video Stina Ramne describes her reserach and the project she got the DPLU Student Prize for.

https://www.ludc.lu.se/article/video-dplu-phd-student-prize-2019-stina-ramne - 2025-04-29

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 12 February 2020 The more sugar we eat, the lower intake of vitamins and minerals we have, show new findings from Lund University Diabetes Centre. Esther González-Padilla Photo: Sara Liedholm High sugar intake has been associated with numerous diseases and conditions such as dental caries, obesity, diabetes, and cardiova

https://www.ludc.lu.se/article/more-sugar-less-vitamins-study-shows - 2025-04-29

Published 24 February 2020 JDRF honors type 1 diabetes research leaders, among them prof Åke Lernmark, Lund University Diabetes Centre. JDRF, the leading global organization funding type 1 diabetes (T1D) research, has announced the winners of five prestigious research awards: the George Eisenbarth Award for T1D Prevention; the Gerold and Kayla Grodsky Basic Research Scientist Award; the Mary Tyler

https://www.ludc.lu.se/article/jdrf-award-ake-lernmark - 2025-04-29

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 26 February 2020 Diabetes, cardiovascular disease, Parkinson's and Alzheimer's disease make up the world’s most common diseases. A new biobank at Lund University in Sweden - the largest of its kind - with stem cells from both those affected and healthy individuals, will contribute to an increased understanding of how the

https://www.ludc.lu.se/article/worlds-largest-stem-cell-biobank-launched - 2025-04-29

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 11 March 2020 Lund University Diabetes Centre (LUDC) was ranked as one of Sweden's three best research environments in the medical sciences in the Final Evaluation of the Linnaeus funding program. - It was really gratifying to read the report. We are very proud to see how the long-term efforts have paid off and positione

https://www.ludc.lu.se/article/ludc-top-ranked-national-evaluation - 2025-04-29

Published 16 March 2020 Message from the LUDC Executive Board. Photo by CDC on Unsplash Dear Friends and colleagues,We are all now well aware that the COVID-19 pandemic is spreading fast in Sweden and around the world. There is a lot of information to digest. Some of this is factual and helpful, but there is also a great deal of poorly informed speculation, that risks promoting anxiety and panic.

https://www.ludc.lu.se/article/updates-covid-19 - 2025-04-29

Published 20 May 2020 A method that will quickly and easily detect diabetic neuropathy, nerve damage caused by high blood sugar, is under development. The aim is to identify individuals in the risk zone so that it is possible to initiate early treatment to prevent, or even reverse, the development. Neuropathy can be difficult to diagnose. It covers many different nerve types, can express itself in

https://www.ludc.lu.se/article/screening-reveals-early-nerve-damage - 2025-04-29

Published 27 March 2020 Article in The Conversation by Paul Franks, professor of genetic epidemiology and Peter M Nilsson, professor of internal medicine - epidemiology at Lund University. Photo by CDC on Unsplash A growing number of Swedish doctors and scientists are raising alarm over the Swedish government’s approach to COVID-19. Unlike its Nordic neighbours, Sweden has adopted a relatively rel

https://www.ludc.lu.se/article/sweden-under-fire-relaxed-coronavirus-approach-heres-science-behind-it - 2025-04-29

Published 27 April 2015 In type 2 diabetes, the body’s cells are unable to assimilate the essential hormone insulin which is produced in the beta cells of the pancreas. Exactly what is wrong with the beta cells in type 2 diabetes is the question to which Professor Erik Renström at Lund University Diabetes Centre is searching for an answer. After just over twenty years of successful research in the

https://www.ludc.lu.se/article/nordic-award-research-what-wrong-beta-cells-type-2-diabetes - 2025-04-29

Published 31 March 2020 Olle Melander, professor of Internal Medicine and consultant at Skåne University Hospital, has received the prestigious European Research Council’s (ERC) Advanced Grant of approximately SEK 25 million. Olle Melander. Photo: Mikael Risedal Olle Melander, Professor of Internal Medicine, does research on new preventive treatments for diabetes and cardiovascular disease.“It fee

https://www.ludc.lu.se/article/olle-melander-awarded-erc-advanced-grants - 2025-04-29

Published 27 March 2020 Oktawia Nilsson's doctoral thesis describes Apolipoprotein A-I (shortly named ApoA-I), the main protein of HDL also known as “the good” cholesterol. Based on the experiments performed in the scientific papers included in this thesis, we propose that ApoA-I can be used as a promising treatment for diabetes and cardiovascular diseases. However, some people with genetic predis

https://www.ludc.lu.se/article/apolipoprotein-i-good-player-dark-side - 2025-04-29

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 5 April 2020 The outbreak of covid19 has made us go more virtual than ever. During Oktawia Nilssons doctoral defense her opponent was connected by Zoom, and so was her relatives who could follow the webinar from Poland. The only thing that has been postponed is the celebration…   Oktawias opponent and her relatives joine

https://www.ludc.lu.se/article/doctoral-defense-corona-style - 2025-04-29

Published 16 April 2020 A new app to fight covid-19 in Sweden by tracking symtoms is on its way. Watch professor Paul Franks when he explains the idea behind it. Watch the video

https://www.ludc.lu.se/article/video-app-will-predict-risk-and-outbreak-coronavirus-sweden - 2025-04-29

Published 29 April 2020 Researchers at Lund University in Sweden have launched a free app to help map the spread of infection in Sweden and increase knowledge of the coronavirus. “Data from the app will give us a clearer picture of the development of the disease and why some people only experience mild symptoms while others get seriously ill and die”, says Paul Franks, professor of genetic epidemi

https://www.ludc.lu.se/article/covid-symptom-tracker-app-launched-sweden - 2025-04-29